Christiana Stamoulis
Director of Finance/CFO bij INCYTE CORPORATION
Vermogen: 9 M $ op 29-02-2024
Profiel
Momenteel is Christiana Stamoulis Chief Financial Officer & Executive Vice President van Incyte Corp. Mevrouw Stamoulis zit ook in de raad van bestuur van Hologic, Inc. In haar loopbaan was zij President & Chief Financial Officer bij Cogent Biosciences, Inc., Senior VP-Strategy & Business Development bij Vertex Pharmaceuticals, Inc., Managing Director-Investment Banking Division bij Citigroup, Inc. en Vice President bij Goldman Sachs & Co. LLC. Mevrouw Stamoulis behaalde een bachelorgraad aan het Massachusetts Institute of Technology en een MBA aan de MIT Sloan School of Management.
Bekende belangen in openbare bedrijven
Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
---|---|---|---|---|
INCYTE CORPORATION
0.04% | 14-02-2024 | 89 983 ( 0.04% ) | 5 M $ | 29-02-2024 |
HOLOGIC, INC.
0.02% | 07-03-2024 | 45 472 ( 0.02% ) | 3 M $ | 29-02-2024 |
Actieve functies van Christiana Stamoulis
Bedrijven | Functie | Begin |
---|---|---|
HOLOGIC, INC. | Director/Board Member | 01-11-2011 |
INCYTE CORPORATION | Director of Finance/CFO | 11-02-2019 |
Eerdere bekende functies van Christiana Stamoulis
Bedrijven | Functie | Einde |
---|---|---|
COGENT BIOSCIENCES, INC. | Director of Finance/CFO | 31-01-2019 |
VERTEX PHARMACEUTICALS INCORPORATED | Corporate Officer/Principal | 01-12-2013 |
CITIGROUP INC. | Corporate Officer/Principal | 01-01-2009 |
Goldman Sachs & Co. LLC
Goldman Sachs & Co. LLC Financial ConglomeratesFinance Goldman Sachs & Co. LLC (GS&Co.) is a securities brokerage firm headquartered in New York City. Founded in 1927, the firm is a subsidiary of The Goldman Sachs Group, Inc. (NYSE: GS). GS&Co. provides services to help hedge funds manage risk, monitor portfolios, maintain liquidity and build their businesses. They offer clients access to global equity and derivatives markets, as well as foreign exchange, commodities, European Lefts, rates and credit across the Americas, Europe and Asia. The firm proactively monitors capital markets, searching for pockets of liquidity and news that may require changes to those strategies. Integration with the Goldman Sachs network gives clients access to the firm's sectored block trades and their insights into price discovery. Their electronic trading program provides clients with tools to manage their trades from pre-trade analytics to post-trade analysis. | Corporate Officer/Principal | - |
Opleiding van Christiana Stamoulis
Massachusetts Institute of Technology | Undergraduate Degree |
MIT Sloan School of Management | Masters Business Admin |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Beursgenoteerde bedrijven | 5 |
---|---|
HOLOGIC, INC. | Health Technology |
INCYTE CORPORATION | Health Technology |
VERTEX PHARMACEUTICALS INCORPORATED | Health Technology |
CITIGROUP INC. | Finance |
COGENT BIOSCIENCES, INC. | Health Technology |
Bedrijven in privébezit | 1 |
---|---|
Goldman Sachs & Co. LLC
Goldman Sachs & Co. LLC Financial ConglomeratesFinance Goldman Sachs & Co. LLC (GS&Co.) is a securities brokerage firm headquartered in New York City. Founded in 1927, the firm is a subsidiary of The Goldman Sachs Group, Inc. (NYSE: GS). GS&Co. provides services to help hedge funds manage risk, monitor portfolios, maintain liquidity and build their businesses. They offer clients access to global equity and derivatives markets, as well as foreign exchange, commodities, European Lefts, rates and credit across the Americas, Europe and Asia. The firm proactively monitors capital markets, searching for pockets of liquidity and news that may require changes to those strategies. Integration with the Goldman Sachs network gives clients access to the firm's sectored block trades and their insights into price discovery. Their electronic trading program provides clients with tools to manage their trades from pre-trade analytics to post-trade analysis. | Finance |